Please assess the completion status of the following clinical trial:

Trial Title: Pain Control in Elderly Hip Fracture Patients: Is Intravenous Acetaminophen Superior to Oral Administration?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Acute, isolated, unilateral femoral neck, intertrochanteric, and per trochanteric hip fractures confirmed by anteroposterior/lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI).~2. Age ≥ 65 years.~3. Low energy mechanism.~4. Hip fracture fixation performed within 48 hours of injury.~5. English speaking.~6. Anticipated medical optimization for operative fixation.~7. No other major trauma.~Exclusion Criteria:~1. Unable to provide informed consent (dementia, limited decision making capacity)~2. Admitted by medical service for significant co-morbidities~3. Retained hardware around the affected hip~4. Infection around the affected hip~5. Transfer patients with a length of stay \> 24 hours at the transferring hospital~6. Known allergy to acetaminophen~7. Current use of narcotics~8. Receiving a regional anesthetic block at any point during the hospitalization~9. Known history of hepatic disease (hepatitis, cirrhosis)~10. Weight \< 50kg~11. Prisoner~12. Involved in another clinical trial that would interfere with the intervention of this study

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PO Acetaminophen (Type: ACTIVE_COMPARATOR): 1,000mg Acetaminophen po every 8 hours until discharge.
- IV Acetaminophen (Type: EXPERIMENTAL): 1,000mg Acetaminophen IV every 8 hours until the patient has received 3 doses post-operatively. Then 1,000mg Acetaminophen po every 8 hours until discharge.

Based on this trial design, predict the completion outcome and termination type (if applicable).